SEC Form 4 · accession 0001209191-19-017631

Xylem Inc. · XYL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — SVP, GC & Corporate Secretary

Period of report

Mar 6, 2019

Accepted (ET)

Mar 7, 2019 · 1:56 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001524472

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F1	Mar 6, 2019	M	5,869	$48.33	A	59,008	D
Common Stock^F2	Mar 6, 2019	S	5,869	$76.3679	D	53,139	D
Common Stock^F3,F4	Mar 6, 2019	S	2,346	$76.3702	D	50,793	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option^F5	$48.33	Mar 6, 2019	M	5,869	D	—	Feb 21, 2027	Common	5,869	11,737	D

F1These options were exercised pursuant to a 10b5-1 plan adopted by the reporting person on February 4, 2019
F2This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $75.85 to $76.81 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price
F3The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on February 4, 2019
F4This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $75.91 to $76.81 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price
F5This grant vests in 3 installments: 5,869 options on February 21, 2018, 5,869 options on February 21, 2019 and 5,868 options on February 21, 2020